BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. AUROBINDO PHARMA LIMITED et al > Summary
Court Case Number 3:19-cv-08840
Filing Date Mar 22, 2019
Termination Date Jun 19, 2019
Court New Jersey District Court
Status Dismissed - Voluntarily
Plaintiff Attorneys
16Boehringer Ingelheim International GmbH
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Boehringer Ingelheim International GmbH
Attorney Name: David Leigh Moses
Saul Ewing LLP
Boehringer Ingelheim International GmbH
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Boehringer Ingelheim Pharmaceuticals
Attorney Name: William C. Baton
Saul Ewing LLP
Boehringer Ingelheim Pharmaceuticals
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Boehringer Ingelheim Pharmaceuticals
Attorney Name: David Leigh Moses
Saul Ewing LLP
Boehringer Ingelheim Pharmaceuticals
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Boehringer Ingelheim International GmbH
Attorney Name: Bruce M. Wexler
Paul Hastings
Boehringer Ingelheim International GmbH
Attorney Name: Eric W. Dittmann
Paul Hastings
Boehringer Ingelheim International GmbH
Attorney Name: Isaac S. Ashkenazi
Paul Hastings
Boehringer Ingelheim International GmbH
Attorney Name: Max H. Yusem
Paul Hastings
Boehringer Ingelheim Pharmaceuticals
Attorney Name: Bruce M. Wexler
Paul Hastings
Boehringer Ingelheim Pharmaceuticals
Attorney Name: Eric W. Dittmann
Paul Hastings
Boehringer Ingelheim Pharmaceuticals
Attorney Name: Isaac S. Ashkenazi
Paul Hastings
Boehringer Ingelheim Pharmaceuticals
Attorney Name: Max H. Yusem
Paul Hastings
Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 06087380 | Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions | Jul 11, 2000 |
